Contract for the provision of Histopathology Reporting

This is a direct award to the incumbent supplier, Poundbury Cancer Institute, under the Provider Selection Regime (PSR) using Process C. The contract is for the provision of outsourced histopathology reporting. The contract term is for one year, from 01/08/2024 to 30/07/2025. The estimated value is £300,000. An option to extend for a further one year has been included, if the incumbent supplier can demonstrate it still meets the required service level criteria and fulfills the guidelines associated with Process C.
As shown in the disclosed criteria, the main criterion is Quality. “Quality and Innovation” is weighted at 50% as the key objective is maintaining a high-quality service. The other elements of quality-led criteria total a further 40% of the weighting. Value in terms of cost has been weighted 10%, because maintaining the quality of the service is the main objective of this award. The Trust has measured the incumbent supplier's current and likely future performance against the criteria and confirm their recommendation to make a direct award via Process C